FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

424905009: Agalsidase alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3688107019 Agalsidase alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3688108012 Agalsidase alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4852151000005111 agalsidase alfa da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase alfa (substance) Is a Alpha-galactosidase false Inferred relationship Some
Agalsidase alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) true Inferred relationship Some
Agalsidase alfa (substance) Is a Galactosidase true Inferred relationship Some
Agalsidase alfa (substance) Is a Recombinant protein (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing agalsidase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase alfa (substance) Inferred relationship Some 1
Product containing only agalsidase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase alfa (substance) Inferred relationship Some 1
Agalsidase alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase alfa (substance) Inferred relationship Some 1
Agalsidase alfa-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase alfa (substance) Inferred relationship Some 1
Pegunigalsidase alfa This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Agalsidase alfa (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start